SEARCH RESULTS for NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

Recent Patent Assignments Patent Assignments - (Total found: 128)

Patent(s) Assignor(s) Orig. Assignee(s) Assignee(s) Reel/Frame

(X0) 11140659: RECONSTITUTED HISTONE METHYLTRANSFERASE COMPLEX AND METHODS OF IDENTIFYING MODULATORS THEREOF

(A1) 20050266473: RECONSTITUTED HISTONE METHYLTRANSFERASE COMPLEX AND METHODS OF IDENTIFYING MODULATORS THEREOF

(B2) 7563589: RECONSTITUTED HISTONE METHYLTRANSFERASE COMPLEX AND METHODS OF IDENTIFYING MODULATORS THEREOF

THE UNIVERISTY OF NORTH CAROLINA AT CHAPEL HILL

N/A

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

41810/850

(X0) 10510992: MATCHED FILTRATION WITH EXPERIMENTAL NOISE DETERMINATION FOR DENOISING, PEAK PICKING AND QUANTITATION IN LC-MS

(A1) 20050261838: MATCHED FILTRATION WITH EXPERIMENTAL NOISE DETERMINATION FOR DENOISING, PEAK PICKING AND QUANTITATION IN LC-MS

(B2) 7409298: MATCHED FILTRATION WITH EXPERIMENTAL NOISE DETERMINATION FOR DENOISING, PEAK PICKING AND QUANTITATION IN LC-MS

NORTHEASTERN

N/A

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR NIH

41662/840

(X0) 14787383: GLYCOSYLATED CARDIOTONIC STEROIDS

(A1) 20160176914: GLYCOSYLATED CARDIOTONIC STEROIDS

NORTHEASTERN UNVIERSITY

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR NIH

41588/122

(X0) 12668713: BUTT JOINT CONNECTIONS FOR CORE MATERIALS

(A1) 20100189954: BUTT JOINT CONNECTIONS FOR CORE MATERIALS

NORTHEASTERN UNVIERSITY

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR NIH

41589/69

(X0) 11413067: Nanoparticulate delivery systems for treating multi-drug resistance

(A1) 20060257493: Nanoparticulate delivery systems for treating multi-drug resistance

NORTHEASTERN UNVIERSITY

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR NIH

41590/973

(X0) 13513149: METHODS OF TREATING FUNGAL INFECTIONS

(A1) 20120252820: METHODS OF TREATING FUNGAL INFECTIONS

NORTHEASTERN UNVIERSITY

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR NIH

41591/468

(X0) 10588392: Monoclonal antibody based biomarker discovery and development platform

(A1) 20070172887: Monoclonal antibody based biomarker discovery and development platform

(B2) 8512959: Monoclonal antibody based biomarker discovery and development platform

NORTHEASTERN UNVIERSITY

N/A

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR NIH

41593/51

(X0) 14389984: Compositions and Methods for the Inhibition of Methyltransferases

(A1) 20150057243: Compositions and Methods for the Inhibition of Methyltransferases

NORTHEASTERN UNVIERSITY

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR NIH

41581/516

(X0) 11791903: INHIBITION OF HSP27 PHOSPHORYLATION FOR THE TREATMENT OF BLISTERING DISORDERS

(A1) 20080207519: INHIBITION OF HSP27 PHOSPHORYLATION FOR THE TREATMENT OF BLISTERING DISORDERS

(B2) 8008093: INHIBITION OF HSP27 PHOSPHORYLATION FOR THE TREATMENT OF BLISTERING DISORDERS

THE UNIVERISTY OF NORTH CAROLINA AT CHAPEL HILL

N/A

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

41568/373

(X0) 10771186: Crystalline PDE4D2 catalytic domain complex, and methods for making and employing same

(A1) 20070015270: Crystalline PDE4D2 catalytic domain complex, and methods for making and employing same

THE UNIVERISTY OF NORTH CAROLINA AT CHAPEL HILL

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

41570/622

(X0) 10511989: CATERPILLER GENE FAMILY

(A1) 20060053496: CATERPILLER GENE FAMILY

(B2) 7569681: CATERPILLER GENE FAMILY

THE UNIVERISTY OF NORTH CAROLINA AT CHAPEL HILL

N/A

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

41536/417

(X0) 12491487: CATERPILLER GENE FAMILY

(A1) 20090291450: CATERPILLER GENE FAMILY

(B2) 7923545: CATERPILLER GENE FAMILY

THE UNIVERISTY OF NORTH CAROLINA AT CHAPEL HILL

N/A

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

41536/465

(X0) 10584960: MODULATION OF EPIDERMAL GROWTH FACTOR HETERODIMER ACTIVITY

(A1) 20100015124: MODULATION OF EPIDERMAL GROWTH FACTOR HETERODIMER ACTIVITY

(B2) 8323987: MODULATION OF EPIDERMAL GROWTH FACTOR HETERODIMER ACTIVITY

THE UNIVERISTY OF NORTH CAROLINA AT CHAPEL HILL

N/A

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

41498/192

(X0) 08744367: METHOD OF TREATING BRONCHITIS WITH URIDINE TRIPHOSPHATE AND RELATED COMPOUNDS

(B1) 6159952: METHOD OF TREATING BRONCHITIS WITH URIDINE TRIPHOSPHATE AND RELATED COMPOUNDS

THE UNIVERISTY OF NORTH CAROLINA AT CHAPEL HILL

N/A

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

41413/828

(X0) 10456947: INHIBITORS OF THE INTERACTION BETWEEN HMGB POLYPEPTIDES AND TOLL-LIKE RECEPTOR 2 AS ANTI-INFLAMMATORY AGENTS

(A1) 20040053841: INHIBITORS OF THE INTERACTION BETWEEN HMGB POLYPEPTIDES AND TOLL-LIKE RECEPTOR 2 AS ANTI-INFLAMMATORY AGENTS

(B2) 7220723: INHIBITORS OF THE INTERACTION BETWEEN HMGB POLYPEPTIDES AND TOLL-LIKE RECEPTOR 2 AS ANTI-INFLAMMATORY AGENTS

FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH

N/A

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

41131/256

(X0) 14364840: METHODS AND SYSTEMS FOR MINIMIZATION OF MECHANICAL EFFECTS OF IMPACT VELOCITY DURING TISSUE PRESERVATION

(A1) 20140331696: METHODS AND SYSTEMS FOR MINIMIZATION OF MECHANICAL EFFECTS OF IMPACT VELOCITY DURING TISSUE PRESERVATION

NORTHEASTERN UNVIERSITY

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR NIH

41099/400

(X0) 13876712: Genetic Modifiers of Cystic Fibrosis

(A1) 20130274132: Genetic Modifiers of Cystic Fibrosis

THE UNIVERISTY OF NORTH CAROLINA AT CHAPEL HILL

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

40981/339

(X0) 14346360: Methods, Kits and Computer Program Products using Hepatocellular Carcinoma (HCC) Biomarkers

(A1) 20140235494: Methods, Kits and Computer Program Products using Hepatocellular Carcinoma (HCC) Biomarkers

THE UNIVERISTY OF NORTH CAROLINA AT CHAPEL HILL

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

40983/83

(X0) 12903614: NITRIC OXIDE-RELEASING COATINGS

(A1) 20110086234: NITRIC OXIDE-RELEASING COATINGS

THE UNIVERISTY OF NORTH CAROLINA AT CHAPEL HILL

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

40983/333

(X0) 13596603: MICROMOLDING OF POLYSTYRENE BY SOFT LITHOGRAPHY

(A1) 20130066031: MICROMOLDING OF POLYSTYRENE BY SOFT LITHOGRAPHY

THE UNIVERISTY OF NORTH CAROLINA AT CHAPEL HILL

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

40983/729

(X0) 08472996: METHOD OF COMBATTING INFECTIOUS DISEASES USING DICATIONIC BIS-BENZIMIDAZOLES

(B1) 5643935: METHOD OF COMBATTING INFECTIOUS DISEASES USING DICATIONIC BIS-BENZIMIDAZOLES

THE UNIVERISTY OF NORTH CAROLINA AT CHAPEL HILL

N/A

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

40983/892

(X0) 08923346: METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING TUMOR CELL GROWTH

(A1) 20020006950: METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING TUMOR CELL GROWTH

(B2) 6552055: METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING TUMOR CELL GROWTH

DANA-FARBER CANCER INSTITUTE

N/A

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39801/620

(X0) 08865297: THE SIV A GENES, NOVEL GENES INVOLVED IN CD27-MEDIATED APOPTOSIS

(B1) 6010853: THE SIV A GENES, NOVEL GENES INVOLVED IN CD27-MEDIATED APOPTOSIS

DANA-FARBER CANCER INSTITUTE

N/A

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39801/686

(X0) 09787097: REGULATION OF IMMUNE RESPONSES BY ATTRACTIN

(B1) 6933132: REGULATION OF IMMUNE RESPONSES BY ATTRACTIN

DANA-FARBER CANCER INSTITUTE

N/A

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39801/754

(X0) 10100534: STABILIZED SOLUBLE GLYCOPROTEIN TRIMERS

(A1) 20050106177: STABILIZED SOLUBLE GLYCOPROTEIN TRIMERS

(B2) 6911205: STABILIZED SOLUBLE GLYCOPROTEIN TRIMERS

DANA-FARBER CANCER INSTITUTE

N/A

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39801/942

(X0) 12146386: Method of Attenuating Reactions to Skin Irritants

(A1) 20080260680: Method of Attenuating Reactions to Skin Irritants

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39802/260

(X0) 10007352: Method of treating hematologic tumors and cancers

(A1) 20020169135: Method of treating hematologic tumors and cancers

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39802/403

(X0) 10209388: METHOD OF TREATING HEMATOLOGIC TUMORS AND CANCERS

(A1) 20030036515: METHOD OF TREATING HEMATOLOGIC TUMORS AND CANCERS

(B2) 7070797: METHOD OF TREATING HEMATOLOGIC TUMORS AND CANCERS

DANA-FARBER CANCER INSTITUTE

N/A

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39802/451

(X0) 10165099: Methods and compositions for the diagnosis of cancer susceptibilities and defective DNA repair mechanisms and treatment thereof

(A1) 20030188326: Methods and compositions for the diagnosis of cancer susceptibilities and defective DNA repair mechanisms and treatment thereof

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39802/636

(X0) 12749419: Methods and Compositions for the Diagnosis of Cancer Susceptibilities and Defective DNA Repair Mechanisms and Treatment Thereof

(A1) 20110257036: Methods and Compositions for the Diagnosis of Cancer Susceptibilities and Defective DNA Repair Mechanisms and Treatment Thereof

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39802/705

(X0) 10293809: Agents that modulate immune cell activation and methods of use thereof

(A1) 20030232323: Agents that modulate immune cell activation and methods of use thereof

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39804/15

(X0) 10897485: Method of modulating apoptosis and compositions thereof

(A1) 20050085420: Method of modulating apoptosis and compositions thereof

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39804/43

(X0) 09951938: MUC1 extracellular domain and cancer treatment compositions and methods derived therefrom

(A1) 20050053606: MUC1 extracellular domain and cancer treatment compositions and methods derived therefrom

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39810/423

(X0) 10447839: MUC1 interference RNA compositions and methods derived therefrom

(A1) 20040018181: MUC1 interference RNA compositions and methods derived therefrom

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39811/880

(X0) 10514531: Methods and composition for modulating type I muscle formation using pgc-1 alpha

(A1) 20060035849: Methods and composition for modulating type I muscle formation using pgc-1 alpha

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39812/447

(X0) 10533839: In vivo imaging of e2f-regulated bioluminescent proteins

(A1) 20060206950: In vivo imaging of e2f-regulated bioluminescent proteins

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39814/873

(X0) 11039075: Compositions and methods to select dendritic cells from a heterogeneous cell population

(A1) 20050208599: Compositions and methods to select dendritic cells from a heterogeneous cell population

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39844/523

(X0) 10658028: BH3 peptides and method of use thereof

(A1) 20040171809: BH3 peptides and method of use thereof

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39844/647

(X0) 10542517: Ndr kinase modulators

(A1) 20070031822: Ndr kinase modulators

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39844/734

(X0) 11227783: Substituted biaryl piperazinyl-pyridine analogues

(A1) 20060142315: Substituted biaryl piperazinyl-pyridine analogues

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39844/796

(X0) 08808847: ANTIVIRAL COMPOUNDS AND METHODS OF USE

(B1) 6686462: ANTIVIRAL COMPOUNDS AND METHODS OF USE

DANA-FARBER CANCER INSTITUTE

N/A

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39845/765

(X0) 08948124: METHODS OF IDENTIFYING AGENTS WHICH ENHANCE CASPASE ACTIVITY

(B1) 7247438: METHODS OF IDENTIFYING AGENTS WHICH ENHANCE CASPASE ACTIVITY

DANA-FARBER CANCER INSTITUTE

N/A

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39845/846

(X0) 09470276: METHOD OF DETECTION OF ALTERATIONS IN MSH5

(A1) 20020187469: METHOD OF DETECTION OF ALTERATIONS IN MSH5

(B2) 6670460: METHOD OF DETECTION OF ALTERATIONS IN MSH5

DANA-FARBER CANCER INSTITUTE

N/A

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39845/894

(X0) 12102300: Method of Detection of Alterations in MSH5

(A1) 20080199876: Method of Detection of Alterations in MSH5

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39845/938

(X0) 10789480: Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same

(A1) 20040231006: Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39846/196

(X0) 10188393: In vivo protein-protein interaction mapping

(A1) 20030013142: In vivo protein-protein interaction mapping

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39846/267

(X0) 09469636: MSH5 ABLATED MICE AND USES THEREFOR

(B1) 6444873: MSH5 ABLATED MICE AND USES THEREFOR

DANA-FARBER CANCER INSTITUTE

N/A

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39846/473

(X0) 10032786: Regulation of cell growth by MUC1

(A1) 20020110841: Regulation of cell growth by MUC1

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39846/597

(X0) 10859935: Pharmaceuticals and methods for treating hypoxia and screening methods therefor

(A1) 20040248233: Pharmaceuticals and methods for treating hypoxia and screening methods therefor

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR

39846/909

(X0) 14086334: INTEGRATED SYSTEM AND METHODS FOR REAL-TIME ANATOMICAL GUIDANCE IN A DIAGNOSTIC OR THERAPEUTIC PROCEDURE

(A1) 20140081133: INTEGRATED SYSTEM AND METHODS FOR REAL-TIME ANATOMICAL GUIDANCE IN A DIAGNOSTIC OR THERAPEUTIC PROCEDURE

(B2) 9451882: INTEGRATED SYSTEM AND METHODS FOR REAL-TIME ANATOMICAL GUIDANCE IN A DIAGNOSTIC OR THERAPEUTIC PROCEDURE

EMORY UNIVERSITY

N/A

36819/127